Evidence map›Paper›PMID 34356559›Full record

ArticleChildren (Basel, Switzerland)2021

Introducing Less-Invasive Surfactant Administration into a Level IV NICU: A Quality Improvement Initiative.

Steven M Conlon, Allison Osborne, Julie Bodie, Jaime Marasch, Rita M Ryan, Tara Glenn

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Characterizing continuous positive airway pressure (CPAP) Belly Syndrome in preterm infants in the neonatal intensive care unit (NICU).Journal of perinatology : official journal of the California Perinatal Association · 2024
    Article
  6. Less invasive surfactant administration methods: Who, what and how.Journal of perinatology : official journal of the California Perinatal Association · 2024
    Review
  7. RDS-NExT workshop: consensus statements for the use of surfactant in preterm neonates with RDS.Journal of perinatology : official journal of the California Perinatal Association · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Steven M ConlonRainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.
Allison OsborneRainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.
Julie BodieRainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.
Jaime MaraschRainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.
Rita M RyanRainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-4588-3412
Tara GlennRainbow Babies & Children's Hospital, Case Western Reserve University, Cleveland, OH 44106, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Less-invasive surfactant administration (LISA), a newer technique of delivering surfactant via a thin catheter, avoids mechanical ventilation. LISA has been widely adopted in Europe but less so in the US. Our goal was to increase the percentage of surfactant delivered via LISA from 0% to 51% by 12/2020. Project planning and literature review started 12/2019, and included a standardized equipment kit and simulation training sessions. We began Plan-Do-Study-Act (PDSA) cycles in 6/2020. Initial exclusions for LISA were gestational age (GA) <28 weeks (w) or ≥36 w, intubation in the delivery room, or PCO2 >70 if known; GA exclusion is now <25 w. From 6 to 12/2020, 97 patients received surfactant, 35 (36%) via LISA. When non-LISA-eligible patients were excluded, 35/42 (83%) received LISA successfully. There were only 2/37 patients for whom LISA was not able to be performed. Three LISA infants required mechanical ventilation in the first week of life. Sedation remained an initial challenge but improved when sucrose was used routinely. LISA was safely and successfully introduced in our NICU.

Indexed as

bronchopulmonary dysplasiaminimally invasive surfactant therapy (MIST)prematurityrespiratory distress syndromesurfactant

Identifiers

PMID34356559
PMCPMC8307302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.